P6111First generation drug eluting stents outperform bare metal stents in 10-year survival

Abstract

1290 Determinants of long-term post-PCI outcomes 2015.146 patients without stent implantation were excluded.We performed a propensity score matched analysis to obtain two groups of 262 patients paired according to DES or BMS implantation and well balanced regarding: baseline characteristics (age, sex, body mass index, hypertension, diabetes, dyslipidemia, smoking, ischemic cardiomyopathy), laboratory data, clinical data (Killip class, heart rate, systolic blood pressure, GRACE score, CRUSADE score), anatomical and procedural data (infarct-related artery, number of diseased vessels, number of lesions treated, number of stents implanted, stent length and diameter) and medication at discharge.(Table 1) Results: During follow-up (median 1015 days) DES patients had lower rates of all-cause mortality (6.5% vs 12.2%, p 0.049), MACE (16.4% vs 25.2%, p 0.049) and a patient-oriented combined endpoint (POCE) of all-cause death, any myocardial infarction and any revascularization (12.6% vs 22.5%, p 0.017).No differences in definitive stent thrombosis were observed.